Trial intelligence / Profile preview

Balneum Plus cream for uraemic pruritus in haemodialysis patients

ISRCTN13971661Phase 4Completed

Sponsor
Portsmouth Hospitals University NHS Trust
Start
Feb 2015
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
01

Overview

Phase 4 trial of polidocanol + urea in chronic kidney disease-associated pruritus (CKD-aP) (2 arms), sponsored by Portsmouth Hospitals University NHS Trust. Primary endpoint: Reduction in itch intensity. Started Feb 2015; status: completed.

02

Drugs

polidocanol + urea
03

Conditions

chronic kidney disease-associated pruritus (CKD-aP)

Beyond the preview

Go deeper on ISRCTN13971661.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN13971661.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call